Watch Demo

2021-2025 Japan Hospital Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for Major Tumor Markers, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers

2021-2025 Japan Hospital Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for Major Tumor Markers, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
  • Publish Date:October 2021

  • Report ID:5951213

  • Format:PDF

  • Publisher:Venture Planning Group

$ 2500

Summary

2021-2025 Japan Hospital Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for Major Tumor Markers, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers

This new report contains 537 pages and 42 tables.

The report is available by section, and can be customized to specific information needs and budget.

The report presents a comprehensive analysis of the Japanese hospital cancer diagnostics market, including: 

  • Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.;
  • Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.;
  • Test volume and sales forecasts for 40 cancer diagnostic procedures performed in Japanese hospitals. ;
  • Current instrumentation technologies and feature comparison of leading analyzers.;
  • Sales and market shares of & leading suppliers.;
  • Emerging diagnostic technologies and their potential market applications.;
  • Product development opportunities.;
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.;
  • Business opportunities and strategic recommendations for supplier

    Contains 537 pages and 42 tables



    Companies Profiled

    Competitive Assessments

    - Abbott
    - Affymetrix
    - Beckman Coulter/Danaher
    - Becton Dickinson
    - bioMerieux
    - Bio-Rad
    - Cepheid
    - Diamedix
    - DiaSorin
    - Eiken Chemical
    - Elitech Group
    - Enzo Biochem
    - Fujirebio
    - Grifols
    - GSK Biologicals
    - Hologic
    - Leica Biosystems
    - Lonza
    - Ortho-Clinical Diagnostics
    - PerkinElmer
    - Qiagen
    - Roche
    - Scienion
    - Sequenom
    - SeraCare
    - Siemens Healthineers
    - Takara Bio
    - Thermo Fisher
    - Wako

Table of contents

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.